Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (1081-1090 of 1,158) with videos related to

Pageof 116
Sort By:
Lancet (London, England)|September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
European Journal of Heart Failure|September 15, 2025
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESCMarianna Adamo, Matteo Pagnesi, Ovidiu Chioncel, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES InitiativeJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Journal of the American College of Cardiology|March 17, 2018
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary SyndromesGiuseppe Gargiulo, Greta Carrara, Enrico Frigoli, et al.
The American Journal of Cardiology|January 7, 2024
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global ProgramGennaro Sardella, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|January 15, 2016
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled TrialsUsman Baber, Gennaro Giustino, Samantha Sartori, et al.
The American Journal of Cardiology|July 16, 2015
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsGennaro Giustino, Usman Baber, Giulio Giuseppe Stefanini, et al.
JACC. Cardiovascular Interventions|July 13, 2026
Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR ScoreDavide Cao, Angelo Oliva, Roxana Mehran, et al.
The New England Journal of Medicine|November 17, 2019
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementGeorge D Dangas, Jan G P Tijssen, Jochen Wöhrle, et al.
Circulation|October 27, 2024
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary InterventionFelice Gragnano, David van Klaveren, Dik Heg, et al.
Pageof 116

Showing results (1081-1090 of 1,158) with videos related to

Sort By:
Pageof 116
Lancet (London, England)|September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
European Journal of Heart Failure|September 15, 2025
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESCMarianna Adamo, Matteo Pagnesi, Ovidiu Chioncel, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES InitiativeJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Journal of the American College of Cardiology|March 17, 2018
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary SyndromesGiuseppe Gargiulo, Greta Carrara, Enrico Frigoli, et al.
The American Journal of Cardiology|January 7, 2024
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global ProgramGennaro Sardella, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|January 15, 2016
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled TrialsUsman Baber, Gennaro Giustino, Samantha Sartori, et al.
The American Journal of Cardiology|July 16, 2015
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsGennaro Giustino, Usman Baber, Giulio Giuseppe Stefanini, et al.
JACC. Cardiovascular Interventions|July 13, 2026
Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR ScoreDavide Cao, Angelo Oliva, Roxana Mehran, et al.
The New England Journal of Medicine|November 17, 2019
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementGeorge D Dangas, Jan G P Tijssen, Jochen Wöhrle, et al.
Circulation|October 27, 2024
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary InterventionFelice Gragnano, David van Klaveren, Dik Heg, et al.
Pageof 116